Apr 04, 2018
RXi Pharmaceuticals to Present an Update on its Clinical and Cosmetic Dermatology Programs at the International Investigative Dermatology Conference
Mar 26, 2018
RXi Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Recent Corporate Highlights
Mar 21, 2018
RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2017 Financial Results on Monday, March 26, 2018
Mar 20, 2018
RXi Pharmaceuticals Selected to Present at the Landmark Venture Forum
Feb 05, 2018
RXi Pharmaceuticals to Present at the BIO CEO and Investor Conference
Jan 24, 2018
RXi Pharmaceuticals Regains Compliance with NASDAQ Listing Requirements
Jan 17, 2018
RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference
Jan 16, 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
Jan 05, 2018
RXi Pharmaceuticals Announces Reverse Stock Split
Dec 29, 2017
RXi Pharmaceuticals to Present at the 10th Annual Biotech Showcase Conference
Dec 18, 2017
RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with RXI-109 for Dermal Scarring
Dec 11, 2017
Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells
Dec 04, 2017
Pre-market Technical Scan on Biotech Equities -- Viking Therapeutics, RXi Pharma, Kitov Pharma, and Auris Medical
Dec 01, 2017
RXi Pharmaceuticals and the Center for Cancer Immune Therapy at Herlev Hospital Announce Research Collaboration
Nov 29, 2017
RXi Pharmaceuticals Announces Positive Results with RXI-231 in Consumer Testing Program
Nov 13, 2017
RXi Pharmaceuticals and Gustave Roussy Announce Research Collaboration
Nov 08, 2017
RXi Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
Nov 07, 2017
RXi Pharmaceuticals Announces Participation in Leading European Healthcare Forums and Conferences
Nov 01, 2017
RXi Pharmaceuticals to Webcast Third Quarter 2017 Financial Results on Wednesday, November 8, 2017
Oct 11, 2017
RXi Pharmaceuticals to Present at the 2017 Annual BIO Investor Forum